BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9545824)

  • 1. [Mutation of WASP in Wiskott-Aldrich syndrome and it's effect on megakaryopoiesis].
    Nonoyama S
    Rinsho Ketsueki; 1998 Feb; 39(2):133-4. PubMed ID: 9545824
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutations of the WASP gene in 10 Japanese patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
    Itoh S; Nonoyama S; Morio T; Imai K; Okawa H; Ochs HD; Shimadzu M; Yata J
    Int J Hematol; 2000 Jan; 71(1):79-83. PubMed ID: 10729999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wiskott-Aldrich syndrome (role of WASP).
    Nonoyama S
    J Med Dent Sci; 2001 Mar; 48(1):1-6. PubMed ID: 12160237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of WASP mutations in 10 Australian families with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
    Bourne HC; Weston S; Prasad M; Edkins E; Benson EM
    Pathology; 2004 Jun; 36(3):262-4. PubMed ID: 15203732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wiskott-Aldrich syndrome protein and platelets.
    Oda A; Ochs HD
    Immunol Rev; 2000 Dec; 178():111-7. PubMed ID: 11213795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Wiskott-Aldrich syndrome.
    Ochs HD; Thrasher AJ
    J Allergy Clin Immunol; 2006 Apr; 117(4):725-38; quiz 739. PubMed ID: 16630926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pleckstrin homology domain of the Wiskott-Aldrich syndrome protein is involved in the organization of actin cytoskeleton.
    Imai K; Nonoyama S; Miki H; Morio T; Fukami K; Zhu Q; Aruffo A; Ochs HD; Yata J; Takenawa T
    Clin Immunol; 1999 Aug; 92(2):128-37. PubMed ID: 10444357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two novel mutations identified in the Wiskott-Aldrich syndrome protein gene cause Wiskott-Aldrich syndrome and thrombocytopenia.
    Andreu N; Matamoros N; Escudero A; Fillat C
    Int J Mol Med; 2007 May; 19(5):777-82. PubMed ID: 17390083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wiskott-Aldrich syndrome iPS cells produce megakaryocytes with defects in cytoskeletal rearrangement and proplatelet formation.
    Ingrungruanglert P; Amarinthnukrowh P; Rungsiwiwut R; Maneesri-le Grand S; Sosothikul D; Suphapeetiporn K; Israsena N; Shotelersuk V
    Thromb Haemost; 2015 Apr; 113(4):792-805. PubMed ID: 25518736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations that cause the Wiskott-Aldrich syndrome impair the interaction of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein.
    Stewart DM; Tian L; Nelson DL
    J Immunol; 1999 Apr; 162(8):5019-24. PubMed ID: 10202051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of six novel WASP gene mutations in patients suffering from Wiskott-Aldrich syndrome.
    Brooimans RA; van den Berg AJ; Tamminga RY; Revesz T; Wulffraat NM; Zegers BJ
    Hum Mutat; 2000 Apr; 15(4):386-7. PubMed ID: 10737997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WASp in immune-system organization and function.
    Thrasher AJ
    Nat Rev Immunol; 2002 Sep; 2(9):635-46. PubMed ID: 12209132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formation.
    Haddad E; Cramer E; Rivière C; Rameau P; Louache F; Guichard J; Nelson DL; Fischer A; Vainchenker W; Debili N
    Blood; 1999 Jul; 94(2):509-18. PubMed ID: 10397718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization.
    Snapper SB; Rosen FS
    Annu Rev Immunol; 1999; 17():905-29. PubMed ID: 10358777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective actin polymerization in EBV-transformed B-cell lines from patients with the Wiskott-Aldrich syndrome.
    Facchetti F; Blanzuoli L; Vermi W; Notarangelo LD; Giliani S; Fiorini M; Fasth A; Stewart DM; Nelson DL
    J Pathol; 1998 May; 185(1):99-107. PubMed ID: 9713366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of Wiskott-Aldrich syndrome with de novo mutation at exon 4.
    Doğu F; Ariga T; Ikincioğullari A; Bozdoğan G; Aytekin C; Metin A; Babacan E
    Turk J Pediatr; 2006; 48(1):66-8. PubMed ID: 16562789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mutations in the Wiskott-Aldrich syndrome protein gene and their effects on transcriptional, translational, and clinical phenotypes.
    Lemahieu V; Gastier JM; Francke U
    Hum Mutat; 1999; 14(1):54-66. PubMed ID: 10447259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of human Wiskott-Aldrich syndrome protein in patients' cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins.
    Huang MM; Tsuboi S; Wong A; Yu XJ; Oh-Eda M; Derry JM; Francke U; Fukuda M; Weinberg KI; Kohn DB
    Gene Ther; 2000 Feb; 7(4):314-20. PubMed ID: 10694812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-linked Wiskott-Aldrich syndrome in a girl.
    Parolini O; Ressmann G; Haas OA; Pawlowsky J; Gadner H; Knapp W; Holter W
    N Engl J Med; 1998 Jan; 338(5):291-5. PubMed ID: 9445409
    [No Abstract]   [Full Text] [Related]  

  • 20. [Wiskott-Aldrich syndrome; evaluation of WASP function in vitro using clinical samples].
    Ariga T
    Nihon Rinsho Meneki Gakkai Kaishi; 2002 Feb; 25(1):135-9. PubMed ID: 11963173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.